SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-17-005238
Filing Date
2017-05-09
Accepted
2017-05-09 16:03:37
Documents
2
Period of Report
2017-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adms8-kq12017.htm 8-K 33749
2 EXHIBIT 99.1 adms991earningsreleaseq120.htm EX-99.1 118622
  Complete submission text file 0001628280-17-005238.txt   153591
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 17826335
SIC: 2834 Pharmaceutical Preparations